BioProcess Insider Interview: Sam Machour, Samsung Biologics

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Sam Machour, Senior Vice President & Chief Quality Officer at Samsung Biologics, spoke with BioProcess Insider editor Dan Stanton about the rapid response by both his company and the wider CDMO sector to biopharma's COVID-19 challenges. He also explained how Samsung Biologics has emerged as one of the largest CDMOs in just 10 years, and discussed future plans for the company in the CDMO space and beyond.
Speaker
photo
Senior Vice President & Chief Quality Officer
Samsung Biologics